Aspen Aerogels (NYSE:ASPN) Rating Reiterated by Roth Mkm

Aspen Aerogels (NYSE:ASPN)‘s stock had its “buy” rating reissued by equities research analysts at Roth Mkm in a research note issued to investors on Tuesday, Benzinga reports. They currently have a $22.00 price target on the construction company’s stock. Roth Mkm’s target price suggests a potential upside of 44.55% from the stock’s previous close.

Other analysts also recently issued research reports about the company. HC Wainwright restated a “buy” rating and issued a $20.00 price target on shares of Aspen Aerogels in a research note on Wednesday, February 14th. TheStreet upgraded Aspen Aerogels from a “d+” rating to a “c-” rating in a research note on Wednesday, March 6th. One research analyst has rated the stock with a sell rating and four have issued a buy rating to the company’s stock. According to data from MarketBeat.com, Aspen Aerogels presently has a consensus rating of “Moderate Buy” and a consensus target price of $19.00.

Aspen Aerogels Stock Down 2.8 %

Shares of NYSE:ASPN opened at $15.22 on Tuesday. Aspen Aerogels has a 52-week low of $5.32 and a 52-week high of $19.10. The firm has a market capitalization of $1.17 billion, a P/E ratio of -23.06 and a beta of 2.04. The stock has a 50 day moving average price of $16.42 and a 200-day moving average price of $13.50. The company has a debt-to-equity ratio of 0.24, a quick ratio of 2.91 and a current ratio of 3.41.

Aspen Aerogels (NYSE:ASPN) last announced its earnings results on Tuesday, February 13th. The construction company reported ($0.01) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.12) by $0.11. Aspen Aerogels had a negative return on equity of 10.47% and a negative net margin of 19.19%. The firm had revenue of $84.22 million during the quarter, compared to analyst estimates of $83.82 million. During the same quarter in the prior year, the company earned ($0.20) EPS. As a group, equities research analysts anticipate that Aspen Aerogels will post -0.24 EPS for the current fiscal year.

Institutional Trading of Aspen Aerogels

Several hedge funds and other institutional investors have recently made changes to their positions in the stock. Banque Cantonale Vaudoise boosted its stake in Aspen Aerogels by 37.5% during the 1st quarter. Banque Cantonale Vaudoise now owns 4,593 shares of the construction company’s stock valued at $81,000 after purchasing an additional 1,252 shares during the last quarter. McAdam LLC purchased a new stake in Aspen Aerogels during the 4th quarter valued at $191,000. Mirae Asset Global Investments Co. Ltd. boosted its stake in Aspen Aerogels by 71.4% during the 3rd quarter. Mirae Asset Global Investments Co. Ltd. now owns 23,052 shares of the construction company’s stock valued at $198,000 after purchasing an additional 9,601 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank boosted its stake in Aspen Aerogels by 38.5% during the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 12,971 shares of the construction company’s stock valued at $205,000 after purchasing an additional 3,607 shares during the last quarter. Finally, Cornerstone Investment Partners LLC purchased a new stake in Aspen Aerogels during the 4th quarter valued at $230,000. Hedge funds and other institutional investors own 97.64% of the company’s stock.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.